secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMARIN CORP PLCUK (AMRN)
CIK:        0000897448
Form:       8-K
Filed at:   2025-10-22T23:59:59+00:00
Accession:  0001193125-25-246973
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amarin promotes David Keenan to EVP, COO effective October 17, 2025
-------------------------------------------------------------------

- David Keenan, previously EVP Technical Operations and President of Europe, appointed COO effective Oct 17, 2025.
- Dr. Keenan joined Amarin in May 2022 as SVP Technical Operations; promoted to EVP in July 2023.
- No change to compensation as a result of the COO appointment; no family relationships or arrangements.
- Keenan brings over 30 years leadership in biopharma; holds PhD in Organic Chemistry and MBA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/897448/000119312525246973/0001193125-25-246973-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/897448/000119312525246973/amrn-20251017.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-246973

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer